Glioma and Metastatic Brain Cancer Clinical Trial Using ExAblate Transcranial System

- The folks at InSightec are studying the effects of ExAblate Transcranial System on Glioma and Metastatic Brain Cancer in individuals ages 18 years to 75 years. This clinical trial is slated to start April 2011 and is expected to end circa December 2014.

Overall Study Contact Info
StatusName Contact Phone

This study is officially titled, "A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors."


Sunnybrook Health Sciences Centre

Toronto, Ontario - Recruiting

For more study details, please visit this link to record, which is the source of this webpage.